Vivus Inc. (VVUS)

Vivus (VVUS) popped $2.375 (33 percent) to $9.563 on the week after receiving two U.S. patents. No. 6,037,346 covers the local administration of phosphodiesterase (PDE) inhibitors and their combinat...